About the Journal

The Canadian Journal of Health Technologies is the open-access, scientific and policy journal of Canada’s Drug Agency (CDA-AMC). Journal articles are published as soon as they are ready and issues are published monthly.

The Canadian Journal of Health Technologies publishes the work of CDA-AMC, including its horizon scans, reimbursement reviews, and health technology assessments. Articles include clinical and cost-effectiveness research, patient perspectives, as well as legal, social, environmental, and implementation reviews. Topics covered are relevant to health policy decision-makers, clinicians, patients, caregivers, the pharmaceutical and medical device industry, and the Canadian and global health technology assessment community.

CDA-AMC is a not for profit organization. It is responsible for providing Canada’s publicly funded health care decision-makers with independent evidence, advice, and recommendations to help inform policy and practice decisions.

CDA-AMC is funded by Canada’s federal, provincial, and territorial governments, except for Quebec.

All views and opinions expressed in the Canadian Journal of Health Technologies are those of the authors and do not necessarily reflect those of CDA-AMC’s funders.